Literature DB >> 11887976

Evidence for the regulation of levels of plasma adhesion molecules by proinflammatory cytokines and their soluble receptors in type 1 diabetes.

V Mohamed-Ali1, L Armstrong, D Clarke, C H Bolton, J H Pinkney.   

Abstract

OBJECTIVES: To investigate the regulation of soluble adhesion molecules by tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6), and relationships with circulating cytokine receptors, in vivo, in type 1 diabetes.
DESIGN: Cross-sectional study.
SETTING: University hospital diabetes clinic.
SUBJECTS: A total of 47 non-nephropathic, Caucasian type 1 diabetics and 39 nondiabetic controls. OUTCOME MEASURES: Plasma levels of TNF-alpha, IL-6, their soluble receptors and adhesion molecules intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1), sE-selectin and von Willebrand factor (vWF), and risk factors for cardiovascular disease.
RESULTS: Plasma concentrations of IL-6 were elevated in diabetic patients compared with controls [median (interquartiles) 1.28 (0.89-2.65) vs. 0.66 (0.45-1.73) pg mL(-1): P=0.016], and in these patients IL-6 and soluble IL-6 receptor (sIL-6R) levels correlated with concentrations of sICAM-1 (r = 0.41, P = 0.012 and r = 0.31, P = 0.04, respectively). Tumour necrosis factor-alpha soluble receptor-2 (sTN-FRII), but not TNF-alpha or tumour necrosis factor soluble receptor-1 (sTNFRI), was elevated in diabetic subjects (P = 0.027). Plasma TNF-alpha levels correlated with sVCAM-1 (r = 0.39, P = 0.008), triglycerides (r = 0.36, P = 0.02 1) and diastolic blood pressure (r = 0.35; P = 0.024). Both sTNFRI and sTNFRII correlated with blood pressure (r = 0.46, P = 0.002; r = 0.32, P = 0.034) and triglycerides (r = 0.33, P = 0.033; r = 0.29, P = 0.05). In contrast, HDL-cholesterol and triglyceride were related to sE-selectin (r = -0.45 and +0.45; both P < 0.001). Neither sE-selectin nor vWF were related to cytokine concentrations. Finally, both TNF-alpha and sIL-6R correlated sTNFRI and RII (r = 0.44-0.49, P < 0.001). None of these interactions were apparent in control subjects.
CONCLUSIONS: (i) IL-6, through effects on sICAM-1, and TNF-alpha via effects on sVCAM-1, may promote vascular adhesion; (ii) plasma levels of TNF-alpha are associated with dyslipidaemia and increased blood pressure, adding to vascular disease risk; (iii) the actions of both cytokines are probably modified by altered production of soluble receptors in diabetic subjects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11887976     DOI: 10.1046/j.1365-2796.2001.00900.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  14 in total

1.  Biomarkers for type 1 diabetes.

Authors:  Sharad Purohit; Jin-Xiong She
Journal:  Int J Clin Exp Med       Date:  2008-02-29

2.  Redox status and immune function in type I diabetes families.

Authors:  E Matteucci; G Malvaldi; F Fagnani; I Evangelista; O Giampietro
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

Review 3.  Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing population.

Authors:  Siang Ing Lee; Mitesh Patel; Christopher M Jones; Parth Narendran
Journal:  Ther Adv Chronic Dis       Date:  2015-11       Impact factor: 5.091

4.  Azelnidipine protects myocardium in hyperglycemia-induced cardiac damage.

Authors:  Vasundhara Kain; Sandeep Kumar; Amrutesh S Puranik; Sandhya L Sitasawad
Journal:  Cardiovasc Diabetol       Date:  2010-12-01       Impact factor: 9.951

5.  Riboflavin alleviates cardiac failure in Type I diabetic cardiomyopathy.

Authors:  Guoguang Wang; Wei Li; Xiaohua Lu; Xue Zhao
Journal:  Heart Int       Date:  2011-11-22

6.  Genetic influences of the intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in development of Type 1 diabetes and diabetic nephropathy.

Authors:  J Ma; A Möllsten; M Prázny; H Falhammar; K Brismar; G Dahlquist; S Efendic; H F Gu
Journal:  Diabet Med       Date:  2006-10       Impact factor: 4.359

7.  No signs of inflammation during knee surgery with ischemia: a study involving inhaled nitric oxide.

Authors:  Lars Hållström; Claes Frostell; Anders Herrlin; Eva Lindroos; Ingrid Lundberg; Anne Soop
Journal:  Mediators Inflamm       Date:  2014-09-18       Impact factor: 4.711

8.  Proteins of TNF-α and IL6 Pathways Are Elevated in Serum of Type-1 Diabetes Patients with Microalbuminuria.

Authors:  Sharad Purohit; Ashok Sharma; Wenbo Zhi; Shan Bai; Diane Hopkins; Leigh Steed; Bruce Bode; Stephen W Anderson; John Chip Reed; R Dennis Steed; Jin-Xiong She
Journal:  Front Immunol       Date:  2018-01-31       Impact factor: 7.561

9.  ISA-2011B, a Phosphatidylinositol 4-Phosphate 5-Kinase α Inhibitor, Impairs CD28-Dependent Costimulatory and Pro-inflammatory Signals in Human T Lymphocytes.

Authors:  Martina Kunkl; Nicla Porciello; Marta Mastrogiovanni; Cristina Capuano; Federica Lucantoni; Chiara Moretti; Jenny L Persson; Ricciarda Galandrini; Raffaella Buzzetti; Loretta Tuosto
Journal:  Front Immunol       Date:  2017-04-26       Impact factor: 7.561

10.  Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice.

Authors:  Pei-Chun Chao; Cheng-Chin Hsu; Mei-Chin Yin
Journal:  Nutr Metab (Lond)       Date:  2009-08-14       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.